KRT18P67

Across TCGA pan-cancer cohorts, KRT18P67 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated KRT18P67 data layer.

The strongest signal is observed in thymoma (THYM), where higher KRT18P67 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated KRT18P67 expression acts as an unfavorable survival marker, although some lineages such as PRAD and STAD show a favorable association.

THYM, ACC, and ESCA are the cancer types where KRT18P67 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THYM	DFS	Tertile	All	0.355	0.832	<.001	66	view →
ACC	OS	Tertile	II,III,IV	0.135	0.658	.010	36	view →
ESCA	DFS	Quartile	All	0.240	0.817	.008	30	view →
SKCM	DFS	Tertile	III,IV	0.084	0.275	.004	24	view →
KICH	DFS	Quartile	All	0.763	1.000	.012	22	view →
UCS	DFS	Tertile	IV	0.318	0.745	.042	18	view →
PRAD	DFS	Median	All	0.965	0.916	.012	14	view →
LUAD	DFS	Tertile	IV	0.357	0.691	.040	12	view →
PAAD	DFS	Tertile	II,III,IV	0.317	0.498	.040	9	view →
UVM	DFS	Tertile	III,IV	0.149	0.670	.043	9	view →
STAD	DFS	Quartile	III,IV	0.633	0.370	.024	9	view →
LUSC	OS	Tertile	III,IV	0.418	0.820	.039	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

KRT18P67–THYM (DFS)

Open the THYM breakdown →